# FDA Inspection 1261471 - Impladent Ltd. - February 19, 2025

Source: https://www.keypedia.com/records/fda_inspections/impladent-ltd/0f92a3da-8d6f-4f17-9fbc-5ecd284d70c3
Source feed: FDA_Inspections

> FDA Inspection 1261471 for Impladent Ltd. on February 19, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261471
- Company Name: Impladent Ltd.
- Inspection Date: 2025-02-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261471 - 2025-02-19](https://www.keypedia.com/records/fda_inspections/impladent-ltd/76c3efb7-8803-44b7-836f-711a50ae5636)
- [FDA Inspection 1068877 - 2018-10-11](https://www.keypedia.com/records/fda_inspections/impladent-ltd/38c067c8-0b98-493f-8af3-241c93153c51)
- [FDA Inspection 1068877 - 2018-10-11](https://www.keypedia.com/records/fda_inspections/impladent-ltd/705561d5-65f7-460c-9cc3-cbe3ec5e4219)
- [FDA Inspection 953515 - 2015-11-12](https://www.keypedia.com/records/fda_inspections/impladent-ltd/c7d4c24a-14ec-44cb-b204-daf34c6e3b0d)
- [FDA Inspection 947769 - 2015-11-05](https://www.keypedia.com/records/fda_inspections/impladent-ltd/46cb33ad-4e0e-4d0d-bee5-07fa87a51497)

Company: https://www.keypedia.com/companies/impladent-ltd/d8713d2d-2746-4f0a-b416-706524f61a7a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d